Neta Simon1,2, Jaclyn Shallat1,2, John Houck1, Prasanna Jagannathan3, Mary Prahl4, Mary K Muhindo5, Abel Kakuru5, Peter Olwoch5, Margaret E Feeney4,6, Whitney E Harrington1,7. 1. Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA. 2. Department of Microbiology, University of Washington, Seattle, Washington, USA. 3. Department of Medicine, Stanford University, Stanford, California, USA. 4. Department of Pediatrics, University of California, San Francisco, California, USA. 5. Infectious Diseases Research Collaboration, Kampala, Uganda. 6. Department of Medicine, University of California, San Francisco, California, USA. 7. Department of Pediatrics, University of Washington, Seattle, Washington, USA.
Abstract
BACKGROUND: Placental malaria has been associated with increased cord blood maternal microchimerism (MMc), which in turn may affect susceptibility to malaria in the offspring. We sought to determine the impact of maternal peripheral Plasmodium falciparum parasitemia during pregnancy on MMc and to determine whether maternal cells expand during primary parasitemia in the offspring. METHODS: We conducted a nested cohort study of maternal-infant pairs from a prior pregnancy malaria chemoprevention study. Maternal microchimerism was measured by quantitative polymerase chain reaction targeting a maternal-specific marker in genomic DNA from cord blood, first P falciparum parasitemia, and preparasitemia. Logistic and negative binomial regression were used to assess the impact of maternal peripheral parasitemia, symptomatic malaria, and placental malaria on cord blood MMc. Generalized estimating equations were used to assess predictors of MMc during infancy. RESULTS: Early maternal parasitemia was associated with increased detection of cord blood MMc (adjusted odds ratio = 3.91, P = .03), whereas late parasitemia, symptomatic malaria, and placental malaria were not. The first parasitemia episode in the infant was not associated with increased MMc relative to preparasitemia. CONCLUSIONS: Maternal parasitemia early in pregnancy may increase the amount of MMc acquired by the fetus. Future work should investigate the impact of this MMc on immune responses in the offspring.
BACKGROUND: Placental malaria has been associated with increased cord blood maternal microchimerism (MMc), which in turn may affect susceptibility to malaria in the offspring. We sought to determine the impact of maternal peripheral Plasmodium falciparum parasitemia during pregnancy on MMc and to determine whether maternal cells expand during primary parasitemia in the offspring. METHODS: We conducted a nested cohort study of maternal-infant pairs from a prior pregnancy malaria chemoprevention study. Maternal microchimerism was measured by quantitative polymerase chain reaction targeting a maternal-specific marker in genomic DNA from cord blood, first P falciparum parasitemia, and preparasitemia. Logistic and negative binomial regression were used to assess the impact of maternal peripheral parasitemia, symptomatic malaria, and placental malaria on cord blood MMc. Generalized estimating equations were used to assess predictors of MMc during infancy. RESULTS: Early maternal parasitemia was associated with increased detection of cord blood MMc (adjusted odds ratio = 3.91, P = .03), whereas late parasitemia, symptomatic malaria, and placental malaria were not. The first parasitemia episode in the infant was not associated with increased MMc relative to preparasitemia. CONCLUSIONS: Maternal parasitemia early in pregnancy may increase the amount of MMc acquired by the fetus. Future work should investigate the impact of this MMc on immune responses in the offspring.
Authors: Sami B Kanaan; Hilary S Gammill; Whitney E Harrington; Stephen C De Rosa; Philip A Stevenson; Alexandra M Forsyth; Judy Allen; Emma Cousin; Koen van Besien; Colleen S Delaney; J Lee Nelson Journal: Oncoimmunology Date: 2017-03-31 Impact factor: 8.110
Authors: Steffanie Sabbaj; Mrinal K Ghosh; Bradley H Edwards; Ruth Leeth; W Don Decker; Paul A Goepfert; Grace M Aldrovandi Journal: J Immunol Date: 2005-03-01 Impact factor: 5.422
Authors: Whitney E Harrington; Theonest K Mutabingwa; Edward Kabyemela; Michal Fried; Patrick E Duffy Journal: Clin Infect Dis Date: 2011-08-01 Impact factor: 9.079
Authors: R McGready; S J Lee; J Wiladphaingern; E A Ashley; M J Rijken; M Boel; J A Simpson; M K Paw; M Pimanpanarak; Oh Mu; P Singhasivanon; N J White; F H Nosten Journal: Lancet Infect Dis Date: 2011-12-12 Impact factor: 25.071
Authors: Kerryn A Moore; Freya J I Fowkes; Jacher Wiladphaingern; Nan San Wai; Moo Kho Paw; Mupawjay Pimanpanarak; Verena I Carrara; Jathee Raksuansak; Julie A Simpson; Nicholas J White; François Nosten; Rose McGready Journal: BMC Med Date: 2017-05-10 Impact factor: 8.775
Authors: Jennifer B Griffin; Victor Lokomba; Sarah H Landis; John M Thorp; Amy H Herring; Antoinette K Tshefu; Stephen J Rogerson; Steven R Meshnick Journal: Malar J Date: 2012-09-10 Impact factor: 2.979